ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 59 filers reported holding ODONATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $29,000 | -27.5% | 9,788 | -15.6% | 0.00% | – |
| Q2 2021 | $40,000 | -41.2% | 11,593 | -41.2% | 0.00% | – |
| Q1 2021 | $68,000 | -57.2% | 19,730 | +139.1% | 0.00% | – |
| Q4 2020 | $159,000 | +20.5% | 8,253 | -16.5% | 0.00% | – |
| Q3 2020 | $132,000 | -68.2% | 9,883 | +0.7% | 0.00% | – |
| Q2 2020 | $415,000 | +159.4% | 9,813 | +68.8% | 0.00% | – |
| Q1 2020 | $160,000 | -64.2% | 5,813 | -57.8% | 0.00% | – |
| Q4 2019 | $447,000 | +89.4% | 13,786 | +51.3% | 0.00% | – |
| Q3 2019 | $236,000 | -14.2% | 9,109 | +21.8% | 0.00% | – |
| Q2 2019 | $275,000 | +554.8% | 7,477 | +289.8% | 0.00% | – |
| Q1 2019 | $42,000 | +425.0% | 1,918 | +218.6% | 0.00% | – |
| Q4 2018 | $8,000 | -83.7% | 602 | -76.3% | 0.00% | – |
| Q3 2018 | $49,000 | +345.5% | 2,543 | +411.7% | 0.00% | – |
| Q2 2018 | $11,000 | -63.3% | 497 | -64.5% | 0.00% | – |
| Q1 2018 | $30,000 | – | 1,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |